In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

has the promise to lead to new paradigms and cost savings in drug development, all of which would strengthen the industry and its ability to develop innovative and much-needed therapies for ...

A new artificial intelligence (AI ... lead to a significant decrease in the cost of drug development, and ultimately the cost of the price of a drug to patients in the future," he said.

On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) ...

Roche is hoping to undercut hugely expensive rivals after the FDA approved ... Zolgensma costs about $2.1m for a single shot of the gene therapy, making it the most expensive drug in the world ...

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...